Randomised, Evaluation-blinded, Crossover, Controlled Study Assessing the Antispastic Efficacy and Safety of Dynamic Night Hand Splinting in Adults With Post-stroke Hemiplegia Treated by Botulimum Toxin (Dysport®) - (a Pilot Study)
Not yet recruiting
Phase of Trial: Phase IV
Latest Information Update: 26 Oct 2017
At a glance
- Drugs Botulinum toxins (Primary)
- Indications Hemiplegia
- Focus Therapeutic Use
- Acronyms ORTHOX
- 16 Oct 2017 Planned End Date changed to 1 Jan 2020.
- 16 Oct 2017 Planned primary completion date changed from 1 Jul 2017 to 1 Jan 2020.
- 16 Oct 2017 Planned initiation date changed to 1 Jan 2018.